학술논문
Health-related Quality of Life with Adjuvant Nivolumab After Radical Resection for High-risk Muscle-invasive Urothelial Carcinoma: Results from the Phase 3 CheckMate 274 Trial
Document Type
Article
Author
Source
In European Urology Oncology October 2022 5(5):553-563
Subject
Language
ISSN
2588-9311